Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Indrani Das Jana, Kawkab Kanjo, Subhanita Roy…·Arindam Mondal
This study analyzes sera from Indian breakthrough infection patients vaccinated with ChAdOx, identifying broad neutralizing activity against SARS-CoV-2 variants, primarily targeting a conserved cryptic class 5 epitope.